INNOVATE Corp. (VATE)
| Market Cap | 165.20M +118.2% |
| Revenue (ttm) | 1.52B +52.4% |
| Net Income | -24.00M |
| EPS | -1.81 |
| Shares Out | 13.64M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 14,276,050 |
| Open | 11.04 |
| Previous Close | 7.41 |
| Day's Range | 10.02 - 14.00 |
| 52-Week Range | 3.75 - 21.30 |
| Beta | 2.37 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 6, 2026 |
About VATE
INNOVATE Corp., through its subsidiaries, operates in infrastructure, life sciences, and spectrum areas in the United States. The company operates through the Infrastructure, Life Sciences, and Spectrum segments. The Infrastructure segment provides industrial construction, structural steel, and facility maintenance services, such as fabrication and erection of structural steel and heavy steel plate services, and large-diameter water pipes and water storage tanks; fabrication of trusses and girders; 3-D building information modeling and detailin... [Read more]
Financial Performance
In 2025, INNOVATE's revenue was $1.25 billion, an increase of 12.55% compared to the previous year's $1.11 billion. Losses were -$64.00 million, 78.8% more than in 2024.
Financial StatementsNews
INNOVATE Earnings Call Transcript: Q2 2026
Q2 2026 revenue surged 74.2% year-over-year to $421.6 million, driven by record Infrastructure results and margin expansion. Net income reached $10.4 million, reversing a prior loss, while strategic refinancing and a pending Broadcasting sale strengthened the balance sheet.
INNOVATE Slides: Q2 2026
INNOVATE has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
INNOVATE Earnings release: Q2 2026
INNOVATE released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
INNOVATE Quarterly report: Q2 2026
INNOVATE has published its Q2 2026 quarterly earnings report on August 6, 2026.
INNOVATE Corp. to Report Second Quarter 2026 Results on August 6th
NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the second quarter 2026 on Thursda...
INNOVATE's Portfolio Company DBM Global to Pay Cash Dividend
NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE:VATE) (“INNOVATE” or the “Company”) announced today that DBM Global Inc. (“DBMG”), a family of companies providing fully integrated st...
INNOVATE Transcript: AGM 2026
Directors and executive officers were introduced, and all four shareholder proposals—including director elections, executive compensation, equity plan amendment, and auditor ratification—were approved. No questions were submitted during the Q&A session.
INNOVATE Announces Successful Closing of Broadcasting Refinancing and Agrees to Partial Sale of Broadcasting
NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that HC2 Broadcasting Holdings Inc. (“Broadcasting”) closed on a refinancing trans...
INNOVATE Earnings Call Transcript: Q1 2026
Q1 2026 saw 33% revenue growth to $364.8M and improved adjusted EBITDA, driven by infrastructure gains, while Life Sciences and Spectrum faced revenue declines. Net loss narrowed, cash increased, and backlog remains strong, supporting a positive outlook.
INNOVATE Slides: Q1 2026
INNOVATE has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 14, 2026.
INNOVATE Earnings release: Q1 2026
INNOVATE released its Q1 2026 earnings on May 14, 2026, summarizing the period's financial results.
INNOVATE Quarterly report: Q1 2026
INNOVATE has published its Q1 2026 quarterly earnings report on May 14, 2026.
INNOVATE Corp. Announces First Quarter 2026 Results
- Infrastructure: Strong first quarter results with revenue of $357.9 million - Life Sciences: MediBeacon receives the CE mark for the Transdermal GFR Monitor and Reusable Sensor - Spectrum: More tha...
INNOVATE Proxy statement: Proxy filing
INNOVATE filed a proxy statement on April 28, 2026, providing details for shareholder voting and corporate governance matters.
INNOVATE Proxy statement: Proxy filing
INNOVATE filed a proxy statement on April 28, 2026, providing details for shareholder voting and corporate governance matters.
INNOVATE Corp. to Report First Quarter 2026 Results on May 14th
NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the first quarter 2026 on Thursday...
MediBeacon® Transdermal GFR Monitor and Reusable Sensor Receive CE Mark Under European Medical Device Regulation
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in...
INNOVATE Earnings Call Transcript: Q4 2025
Fourth quarter revenue surged 61.7% year-over-year, driven by infrastructure, while net loss narrowed. Life sciences and spectrum segments faced headwinds, but regulatory wins and backlog growth position the company for 2026 expansion.
INNOVATE Annual report: Q4 2025
INNOVATE has published its Q4 2025 annual report on March 26, 2026.
INNOVATE Earnings release: Q4 2025
INNOVATE released its Q4 2025 earnings on March 26, 2026, summarizing the period's financial results.
INNOVATE Slides: Q4 2025
INNOVATE has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 26, 2026.
INNOVATE Corp. Announces Fourth Quarter and Full Year 2025 Results
- Infrastructure: NYC and Western markets continue to demonstrate positive project momentum - - Life Sciences: R2 Secures 600‑System Commitment in China - - Spectrum: Recent network launches set to de...
INNOVATE Corp. to Report Fourth Quarter and Full Year 2025 Results on March 26th
NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the fourth quarter and full year 2...
Transdermal GFR Article Recognized as One of Five 2025 Editors' Choice Articles by Journal of the American Society of Nephrology (JASN)
NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in ...
INNOVATE Corp.’s DBM Global to pay $1.30 per share dividend
INNOVATE Corp. (VATE) announced that DBM Global, an operating subsidiary of INNOVATE, will pay a cash dividend of approximately $5M, or $1.30 per share, on February 24, 2026 to DBMG’s…